tyrosine and Hepatitis B Virus Infection

tyrosine has been researched along with Hepatitis B Virus Infection in 6 studies

Research

Studies (6)

TimeframeStudies, this research(%)All Research%
pre-19901 (16.67)18.7374
1990's0 (0.00)18.2507
2000's3 (50.00)29.6817
2010's1 (16.67)24.3611
2020's1 (16.67)2.80

Authors

AuthorsStudies
Caillet-Saguy, C; Colcombet-Cazenave, B; Duchateau, M; Genera, M; Haouz, A; König, A; Matondo, M; Mechaly, A; Neuveut, C; Nourisson, A; Quioc-Salomon, B; Windisch, MP; Wolff, N1
Gao, YJ; Jin, B; Li, HW; Liu, ZW; Ma, XM; Meng, FP; Su, HB; Zhang, M; Zhao, JM1
Denizli, A; Say, R; Unal, S; Uzun, L1
Fan, J; Liang, WF; Xie, YJ; Yang, DH; Zhao, NF1
Cakir, N; Midilli, K; Pamuk, ON; Umit, H1
Finegold, MJ; Weinberg, AG1

Reviews

1 review(s) available for tyrosine and Hepatitis B Virus Infection

ArticleYear
Primary hepatic tumors of childhood.
    Human pathology, 1983, Volume: 14, Issue:6

    Topics: Adenocarcinoma; Adenoma; Adolescent; Adult; Bile Duct Neoplasms; Bile Ducts; Carcinoma, Hepatocellular; Child; Child, Preschool; Female; Hemangioma; Hemangiosarcoma; Hepatitis; Hepatitis B; Humans; Hyperplasia; Infant; Liver Cirrhosis, Biliary; Liver Neoplasms; Male; Metabolism, Inborn Errors; Neoplasms, Germ Cell and Embryonal; Prognosis; Sex Factors; Tyrosine

1983

Other Studies

5 other study(ies) available for tyrosine and Hepatitis B Virus Infection

ArticleYear
Molecular basis of the interaction of the human tyrosine phosphatase PTPN3 with the hepatitis B virus core protein.
    Scientific reports, 2021, 01-13, Volume: 11, Issue:1

    Topics: Capsid; Hepatitis B; Hepatitis B Core Antigens; Hepatitis B virus; Humans; PDZ Domains; Protein Tyrosine Phosphatase, Non-Receptor Type 3; Protein Tyrosine Phosphatases; Tyrosine; Viral Core Proteins

2021
Clinical-pathological analysis of hepatitis B virus recurrence after liver transplantation in Chinese patients.
    Journal of gastroenterology and hepatology, 2014, Volume: 29, Issue:3

    Topics: Adult; Age Factors; Antiviral Agents; Aspartic Acid; Carcinoma, Hepatocellular; China; DNA, Viral; Drug Therapy, Combination; End Stage Liver Disease; Guanine; Hepatitis B; Hepatitis B e Antigens; Hepatitis B virus; Humans; Immunoglobulins; Lamivudine; Liver Neoplasms; Liver Transplantation; Male; Methionine; Middle Aged; Mutation; Retrospective Studies; Risk Factors; Secondary Prevention; Sex Factors; Tyrosine

2014
Production of surface plasmon resonance based assay kit for hepatitis diagnosis.
    Biosensors & bioelectronics, 2009, May-15, Volume: 24, Issue:9

    Topics: Adsorption; Gold; Hepatitis B; Hepatitis B Antibodies; Humans; Kinetics; Microscopy, Atomic Force; Models, Chemical; Polyhydroxyethyl Methacrylate; Sensitivity and Specificity; Surface Plasmon Resonance; Surface Properties; Tyrosine

2009
PCR restriction fragment length polymorphism in detection of YMDD variants of viral polymerase in hepatitis B virus patients treated with lamivudine.
    Hepatobiliary & pancreatic diseases international : HBPD INT, 2002, Volume: 1, Issue:2

    Topics: Adolescent; Adult; Amino Acid Motifs; Aspartic Acid; Base Sequence; Child; DNA-Directed DNA Polymerase; Drug Resistance; Genetic Variation; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Reverse Transcriptase Inhibitors; Tyrosine

2002
Successful treatment with adefovir of one patient whose cryoglobulinemic vasculitis relapsed under lamivudine therapy and who was diagnosed to have HBV virologic breakthrough with YMDD mutations.
    Internal medicine (Tokyo, Japan), 2006, Volume: 45, Issue:21

    Topics: Adenine; Amino Acid Motifs; Aspartic Acid; Cryoglobulinemia; Female; Hepatitis B; Hepatitis B virus; Humans; Lamivudine; Methionine; Middle Aged; Mutation; Organophosphonates; Recurrence; Tyrosine; Vasculitis

2006